1. Home
  2. ELDN vs FUNC Comparison

ELDN vs FUNC Comparison

Compare ELDN & FUNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • FUNC
  • Stock Information
  • Founded
  • ELDN 2004
  • FUNC 1900
  • Country
  • ELDN United States
  • FUNC United States
  • Employees
  • ELDN N/A
  • FUNC N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • FUNC Major Banks
  • Sector
  • ELDN Health Care
  • FUNC Finance
  • Exchange
  • ELDN Nasdaq
  • FUNC Nasdaq
  • Market Cap
  • ELDN 202.4M
  • FUNC 211.3M
  • IPO Year
  • ELDN N/A
  • FUNC N/A
  • Fundamental
  • Price
  • ELDN $2.63
  • FUNC $34.50
  • Analyst Decision
  • ELDN Strong Buy
  • FUNC
  • Analyst Count
  • ELDN 2
  • FUNC 0
  • Target Price
  • ELDN $12.50
  • FUNC N/A
  • AVG Volume (30 Days)
  • ELDN 996.9K
  • FUNC 21.7K
  • Earning Date
  • ELDN 08-14-2025
  • FUNC 07-21-2025
  • Dividend Yield
  • ELDN N/A
  • FUNC 2.52%
  • EPS Growth
  • ELDN N/A
  • FUNC 62.98
  • EPS
  • ELDN 0.21
  • FUNC 3.66
  • Revenue
  • ELDN N/A
  • FUNC $81,451,000.00
  • Revenue This Year
  • ELDN N/A
  • FUNC $16.22
  • Revenue Next Year
  • ELDN N/A
  • FUNC $6.20
  • P/E Ratio
  • ELDN $12.40
  • FUNC $9.55
  • Revenue Growth
  • ELDN N/A
  • FUNC 16.98
  • 52 Week Low
  • ELDN $2.38
  • FUNC $24.66
  • 52 Week High
  • ELDN $5.54
  • FUNC $42.50
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 36.28
  • FUNC 58.16
  • Support Level
  • ELDN $2.54
  • FUNC $31.71
  • Resistance Level
  • ELDN $2.82
  • FUNC $35.88
  • Average True Range (ATR)
  • ELDN 0.21
  • FUNC 1.26
  • MACD
  • ELDN -0.08
  • FUNC 0.11
  • Stochastic Oscillator
  • ELDN 20.00
  • FUNC 66.27

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About FUNC First United Corporation

First United Corp is active in the financial services domain. The scope of its offering includes checking, savings, money market deposit accounts and certificates of deposit, business loans, personal loans, mortgage loans and lines of credit extended to both individuals and businesses. The bank also provides residential real estate construction loans to builders and individuals for single-family dwellings. The company's reportable operating segments include community banking and wealth management. The company generates the majority of its revenue from the Community Banking segment, which is engaged in delivering financial products and services, including various loan and deposit products, to consumer, business, and not-for-profit customers.

Share on Social Networks: